Kyleena 19.5 MG systems
Ended Awarded
- Contract number
- SPE2DB25FT1Y9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,958
Award facts
- Contract value 100% obligated
- $4,957.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,957.52 to DMS Pharmaceutical Group Inc. for Kyleena 19.5 mg systems, with an ultimate completion date of August 20, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected through a firm fixed-price contract with no set-aside designation. The delivery order represents a discrete purchase under the company's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026, which authorizes the agency to issue purchase orders for an extensive range of pharmaceutical products supporting military healthcare facilities nationwide.
This delivery order falls within DMS Pharmaceutical Group's established role as a critical supplier in the federal pharmaceutical supply chain for the Department of Defense. The Kyleena product—a hormonal contraceptive implant system—aligns with the company's portfolio of pharmaceutical and medical supply deliveries, which encompasses prescription medications, biologics, and specialty pharmaceuticals. As the sole awardee on this delivery order, DMS Pharmaceutical Group will distribute the product directly to military health facilities. The firm fixed-price structure and modest order value reflect routine pharmaceutical procurement operations typical of the DLA's supply chain management activities.
Quick answers
Who was awarded contract SPE2DB25FT1Y9?
SPE2DB25FT1Y9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 30, 2025.
How much is contract SPE2DB25FT1Y9 worth?
The government has obligated $4,958 on SPE2DB25FT1Y9.
Is contract SPE2DB25FT1Y9 an order under another contract?
Yes. SPE2DB25FT1Y9 is a delivery order under SPE2DB20D9371, an indefinite delivery contract.
Was contract SPE2DB25FT1Y9 competed?
The extent of competition for SPE2DB25FT1Y9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award